Editorial Commentary: Congenital Cytomegalovirus Infection and Its Prevention
Open Access
- 1 April 2004
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 38 (7) , 1038-1039
- https://doi.org/10.1086/382542
Abstract
Whether likened to a “changeling demon” [1] or to the “troll of transplantation” [2], the human cytomegalovirus (HCMV) has long been known to exact a heavy toll on morbidity and mortality rates among newborn children and immunosuppressed individuals. A recent analysis by the Institute of Medicine of the National Academy of Sciences placed the development of a vaccine against HCMV in its highest category of priority: vaccines that would actually save money for society once they were applied [3]. The same conclusion was reached in a previous analysis [4].Keywords
This publication has 13 references indexed in Scilit:
- Interval between Births and Risk of Congenital Cytomegalovirus InfectionClinical Infectious Diseases, 2004
- Intrauterine Transmission of Cytomegalovirus to Infants of Women with Preconceptional ImmunityNew England Journal of Medicine, 2001
- Development of a cytomegalovirus vaccine: lessons from recent clinical trialsExpert Opinion on Biological Therapy, 2001
- Where rubella is still a problemThe Pediatric Infectious Disease Journal, 1999
- Symptomatic congenital cytomegalovirus infection after maternal recurrent infectionThe Pediatric Infectious Disease Journal, 1994
- The Outcome of Congenital Cytomegalovirus Infection in Relation to Maternal Antibody StatusNew England Journal of Medicine, 1992
- Effectiveness and Cost Benefit of a Proposed Live Cytomegalovirus Vaccine in the Prevention of Congenital DiseaseClinical Infectious Diseases, 1990
- Molecular epidemiology of cytomegalovirusThe Pediatric Infectious Disease Journal, 1986
- Congenital Cytomegalovirus InfectionNew England Journal of Medicine, 1982
- Cytomegalovirus: the troll of transplantationArchives of internal medicine (1960), 1979